eHealth director Francis Soistman Jr sells $28,174 in common stock
eHealth director Francis Soistman Jr sells $28,174 in common stock
Francis S. Soistman Jr., a director at eHealth, Inc. (NASDAQ:EHTH), sold a total of 40,612 shares of common stock in early October 2026. These sales, executed at weighted average prices between $0.6913 and $0.6962 per share, amounted to $28,174 and were part of a Rule 10b5-1 trading plan adopted on June 1, 2026.
On October 1, 2026, Mr. Soistman Jr. disposed of 20,306 shares at a weighted average price of $0.6962. Individual sales for this transaction occurred at prices ranging from $0.6905 to $0.7149. The following day, October 2, 2026, an additional 20,306 shares were sold at a weighted average price of $0.6913, with individual transaction prices ranging from $0.6801 to $0.7023. Following these transactions, Mr. Soistman Jr. beneficially owns 974,609 shares of eHealth common stock.The insider sale comes as EHTH shares trade at $0.67, down 85% year-to-date and sitting at their 52-week low. Despite the steep decline, InvestingPro analysis suggests the stock is undervalued, with a Fair Value of $0.97—placing it on the platform’s most undervalued stocks list. Investors seeking deeper insights can access the comprehensive Pro Research Report, available for EHTH and 1,400+ US equities.
In other recent news, eHealth reported its second-quarter 2026 earnings, revealing a total revenue of $33.6 million. This figure was essentially in line with Wall Street’s forecast of $33.62 million. Despite matching revenue expectations, the company experienced a wider net loss and a larger adjusted EBITDA loss. However, there was a significant improvement in operating cash flow compared to the previous year. In response to these financial results, RBC Capital lowered its price target for eHealth from $3.00 to $2.00, while maintaining a Sector Perform rating. The firm adjusted its model following the earnings release, noting that the revenue fell short of its own estimate of $34.7 million. These developments come as eHealth continues its strategic shift toward a lifetime advisory model.